Key facts
- This page summarizes John P. Saharek's Form 4 filing for HARROW, INC. (HROW).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 Apr 2025, 21:54.
John P. Saharek - 03 Apr 2025 Form 4 Insider Report for HARROW, INC. (HROW)
- Reporting relationship
- CEO & President, ImprimisRx
- Issuer ticker
- HROW
- Reported as of
- 03 Apr 2025
- Net transaction value
- -$2,527,778
- SEC form
- 4
- Accepted by SEC
- 07 Apr 2025, 21:54:53 UTC
- Prior SEC filing
- 13 Sep 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ John P. Saharek
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John P. Saharek filed Form 4 for HARROW, INC. (HROW) on 07 Apr 2025.
Change
- Previous filing in this sequence was filed on 13 Sep 2024.
- Current net transaction value: -$2,527,778.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HROW
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +277,200
- Change %
- +93%
- Price
- $0.000000
- Shares after
- 576,863
- Date
- 03 Apr 2025
- Ownership
- Direct
- Footnotes
- F1
HROW
transaction
Common Stock
Tax liability
- Transaction value
- $2,527,778
- Shares
- -109,475
- Change %
- -19%
- Price
- $23.09
- Shares after
- 467,388
- Date
- 07 Apr 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HROW
transaction
Derivative
Performance Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -277,200
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 03 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 277,200
- Exercise price
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The 277,200 shares of Harrow, Inc. ("Harrow") common stock listed in Table I as "Acquired" represent shares upon vesting of performance stock units ("PSUs") granted to Mr. Saharek under Harrow's 2017 Stock Incentive and Awards Plan (the "Incentive Plan") on April 3, 2023. The PSUs vested on April 3, 2025 and were settled in full in shares of Harrow common stock (on a one-for-one basis) on April 7, 2025, following attainment of (i) a two-year service period, and (ii) the achievement of Harrow common stock price targets ranging from $25 - $50. The 109,475 shares of Harrow common stock listed in Table I as "Disposed" were not sold by Mr. Saharek in any market transaction; rather, they were shares of Harrow common stock withheld by the Company for payroll tax purposes from the same aforementioned 277,200 shares pursuant to the terms of the Incentive Plan.